Zacks Research Predicts Perrigo's Q2 Earnings (NYSE:PRGO)

Perrigo Company plc (NYSE:PRGO - Free Report) - Stock analysts at Zacks Research cut their Q2 2025 earnings per share estimates for shares of Perrigo in a research report issued to clients and investors on Wednesday, May 28th. Zacks Research analyst S. Ganoria now forecasts that the company will post earnings of $0.60 per share for the quarter, down from their prior estimate of $0.70. The consensus estimate for Perrigo's current full-year earnings is $2.56 per share. Zacks Research also issued estimates for Perrigo's Q4 2025 earnings at $0.99 EPS, Q2 2026 earnings at $0.80 EPS, Q1 2027 earnings at $0.62 EPS and FY2027 earnings at $3.54 EPS.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.04. The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.09 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The company's revenue was down 3.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.29 earnings per share.

Separately, Wall Street Zen raised Perrigo from a "hold" rating to a "buy" rating in a research note on Saturday, May 24th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Perrigo currently has a consensus rating of "Hold" and a consensus price target of $33.00.

Perrigo Trading Down 0.8%

Shares of Perrigo stock traded down $0.22 on Friday, reaching $26.49. 266,889 shares of the company were exchanged, compared to its average volume of 1,501,257. The stock has a fifty day moving average price of $26.09 and a 200-day moving average price of $26.19. The firm has a market capitalization of $3.64 billion, a price-to-earnings ratio of -22.64 and a beta of 0.45. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. Perrigo has a fifty-two week low of $23.14 and a fifty-two week high of $30.93.

Perrigo Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Friday, May 30th will be paid a dividend of $0.29 per share. The ex-dividend date is Friday, May 30th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.38%. Perrigo's dividend payout ratio (DPR) is presently -88.55%.

Insider Buying and Selling

In other news, EVP Ronald Craig Janish sold 7,800 shares of the company's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the transaction, the executive vice president now directly owns 33,666 shares of the company's stock, valued at $923,795.04. This represents a 18.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.70% of the stock is owned by insiders.

Institutional Trading of Perrigo

Institutional investors and hedge funds have recently bought and sold shares of the business. Geneos Wealth Management Inc. increased its stake in shares of Perrigo by 439.1% during the first quarter. Geneos Wealth Management Inc. now owns 965 shares of the company's stock worth $27,000 after purchasing an additional 786 shares during the period. Headlands Technologies LLC increased its stake in shares of Perrigo by 1,942.0% during the fourth quarter. Headlands Technologies LLC now owns 1,409 shares of the company's stock worth $36,000 after purchasing an additional 1,340 shares during the period. Picton Mahoney Asset Management bought a new position in shares of Perrigo during the first quarter worth approximately $42,000. Parallel Advisors LLC increased its stake in shares of Perrigo by 176.9% during the first quarter. Parallel Advisors LLC now owns 1,714 shares of the company's stock worth $48,000 after purchasing an additional 1,095 shares during the period. Finally, First Horizon Advisors Inc. increased its stake in shares of Perrigo by 138.3% during the first quarter. First Horizon Advisors Inc. now owns 1,754 shares of the company's stock worth $49,000 after purchasing an additional 1,018 shares during the period. Institutional investors own 95.91% of the company's stock.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.